Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
---|
11/03/2011 | US20110269233 Compositions and methods for regulating cell osmolarity |
11/03/2011 | US20110269232 Method for culturing animal hepatocyte |
11/03/2011 | US20110269231 Proteoglycan-binding peptides that modulate stem cell behavior |
11/03/2011 | US20110269230 Methods and compositions for maintaining genomic stability in cultured stem cells |
11/03/2011 | US20110269229 Methods of inhibiting viral replication |
11/03/2011 | US20110269228 Storage unit for at least one device for identifying animals and/or collecting animal tissue, and corresponding method for identifying or collecting tissue |
11/03/2011 | US20110269227 Peptide having bindability with adiponectin, analysis method utilizing same peptide, and analysis device utilizing same peptide |
11/03/2011 | US20110269226 Microfluidic Continuous Flow Device for Culturing Biological Material |
11/03/2011 | US20110269213 Fungal Endoglucanases, Their Production and Use |
11/03/2011 | US20110269212 Fungal Endoglucanases, Their Production and Use |
11/03/2011 | US20110269207 Cell and biofactor printable biopapers |
11/03/2011 | US20110269206 Polypeptides Having Catalase Activity And Polynucleotides Encoding Same |
11/03/2011 | US20110269198 Methods for control of flux in metabolic pathways |
11/03/2011 | US20110269190 Barriers for facilitating biological reactions |
11/03/2011 | US20110269188 Polypeptides having feruloyl esterase activity and polynucleotides encoding same |
11/03/2011 | US20110269187 High Affinity Human Antibodies to Human IL-18 Receptor |
11/03/2011 | US20110269186 Antibodies against vascular endothelial growth factor receptor-1 |
11/03/2011 | US20110269178 Fluorescent cdk inhibitors for treatment of cancer |
11/03/2011 | US20110269176 Methods for assaying responses to vaccines |
11/03/2011 | US20110269175 Methods for sorting particles |
11/03/2011 | US20110269174 Regulators of nfat |
11/03/2011 | US20110269173 Method for Producing Polarized Retinal Progenitor Cells from Pluripotent Stem Cells and their Differentiation into Retinal Pigment Epithelium Cells |
11/03/2011 | US20110269166 Sealing surface sampling probe applied to blood spots and tissues |
11/03/2011 | US20110269152 Anchoring/capturing system for selecting or analyzing a CHO cell according to a product secreted by the CHO cell |
11/03/2011 | US20110269146 Expression Vectors and Cell Lines Expressing Vascular Endothelial Growth Factor D, and Method of Treating Melanomas |
11/03/2011 | US20110269144 Ryanodine receptor polypeptides |
11/03/2011 | US20110269123 Marker for gastric cancer and method for detecting gastric cancer |
11/03/2011 | US20110269119 Encoding text into nucleic acid sequences |
11/03/2011 | US20110269116 Cell Line From Rousettus As Host Cell For Pathogen Amplification |
11/03/2011 | US20110268791 Porous nanoparticle supported lipid bilayer nanostructures |
11/03/2011 | US20110268790 Snake Factor V and Methods of Use Thereof as a Procoagulant |
11/03/2011 | US20110268774 preparation of stem cells with reprogrammed cell signalling, a method of producing the preparation and a method of use thereof |
11/03/2011 | US20110268773 Inclusion bodies, bacterial cells and compositions containing them and uses thereof |
11/03/2011 | US20110268767 Use of allogeneic cell lines to load antigen-presenting cells to elicit or eliminate immune responses |
11/03/2011 | US20110268766 Engineered Cells Expressing Multiple Immunomodulators And Uses Thereof |
11/03/2011 | US20110268764 Immune response inducing preparations |
11/03/2011 | US20110268757 Use of phenol-soluble modulins for vaccine development |
11/03/2011 | US20110268754 Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy |
11/03/2011 | US20110268752 Inducible Regulatory T-Cell Generation for Hematopoietic Transplants |
11/03/2011 | US20110268750 Chimeric polynucleotides and polypeptides enabling secretion of a polypeptide of interest in association with exosomes and use thereof for the production of immunogenic compositions |
11/03/2011 | US20110268748 NURR-1 Interacting Protein (NuIP) |
11/03/2011 | US20110268746 Human cytomegalovirus neutralizing antibodies and use thereof |
11/03/2011 | US20110268744 Method of Diagnosis of Infection by Mycobacteria and Reagents Therefor |
11/03/2011 | US20110268740 Fully human influenza m2 specific antibodies |
11/03/2011 | US20110268739 Human binding molecules having killing activity against enterococci and uses thereof |
11/03/2011 | US20110268737 Hla-g proteins and pharmaceutical uses thereof |
11/03/2011 | US20110268735 Multimeric constructs |
11/03/2011 | US20110268733 ANTI-Siglec-15 ANTIBODY |
11/03/2011 | US20110268727 Anti-interferon-alpha antibodies |
11/03/2011 | US20110268726 Anti-CD38 human antibodies and uses thereof |
11/03/2011 | US20110268724 Methods and materials relating to cd84-like polypeptides and polynucleotides |
11/03/2011 | US20110268722 Combination therapies with mitochondrial-targeted anti-tumor agents |
11/03/2011 | US20110268716 Methods for the enrichment of viable foxp3+ cells and uses thereof |
11/03/2011 | US20110268714 CD34 Stem Cell-Related Methods and Compositions |
11/03/2011 | US20110268713 Variants of Ancestral Uricases and Uses Thereof |
11/03/2011 | US20110268712 Stem Cells Suitable for Transplantation, Their Preparation and Pharmaceutical Compositions Comprising Them |
11/03/2011 | US20110268711 Pancreatic stellate cell specific promoter and uses thereof |
11/03/2011 | US20110268709 Generation of Histocompatible Tissues Using Nuclear Transplantation |
11/03/2011 | US20110268708 Adipose tissue-derived stem cells for veterinary use |
11/03/2011 | US20110268706 Preparation method of porous hyaluronic acid sponge for cell delivery system |
11/03/2011 | US20110268705 Hdac4, hdac5, hdac6, hdac7, and hif1 alpha modulation of retinal cell survival |
11/03/2011 | US20110268694 Methods for treating vascular leak syndrome |
11/03/2011 | US20110268661 Fluorescent fusion polypeptides and methods of use |
11/03/2011 | US20110268654 Compositions and methods for delivering a substance to a biological target |
11/03/2011 | CA2795461A1 Improved cell cultivation process |
11/02/2011 | EP2383343A2 Recombinant varicella-zoster virus |
11/02/2011 | EP2383338A1 Process for production of human type III collagen |
11/02/2011 | EP2383336A1 Peptide capable of binding to immunoglobulin |
11/02/2011 | EP2383334A1 Feeder cell for target cell induction |
11/02/2011 | EP2383333A1 Method for producing polarized retinal progenitor cells from pluripotent stem cells and their differentiation into retinal pigment epithelium cells |
11/02/2011 | EP2383332A1 Method for culture of animal hepatocyte |
11/02/2011 | EP2383296A1 Antibody for the thyrotropin receptor and uses thereof |
11/02/2011 | EP2383295A1 IP-10 antibodies and their uses |
11/02/2011 | EP2383291A2 Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto |
11/02/2011 | EP2383290A2 Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto |
11/02/2011 | EP2383278A1 Method to determine B cell mediated diseases |
11/02/2011 | EP2382982A2 Neural regeneration peptide and methods for their use in treatment of brain damage |
11/02/2011 | EP2382317A1 Tor-interacting proteins (tips) and genes therefor |
11/02/2011 | EP2382312A2 Methods of producing isoprene and a co-product |
11/02/2011 | EP2381789A1 Primed cell therapy |
11/02/2011 | EP2381761A1 Genetically engineered herbicide resistant algae |
11/02/2011 | EP2014773B1 Method of determining cell peeling, method of peeling cultured cells, device for determining cell peeling and automated cell culture apparatus |
11/02/2011 | EP2013730B1 Mineralized three-dimensional bone constructs |
11/02/2011 | EP1934333B1 Method for obtaining human smooth muscular cells and uses thereof |
11/02/2011 | EP1836225B1 Kir-binding agents and methods of use thereof |
11/02/2011 | EP1615952B1 Methods of treatment of inflammatory diseases using specific binding agents of human angiopoietin-2 |
11/02/2011 | EP1569510B1 Microfluidic device for cell separation and uses thereof |
11/02/2011 | EP1510581B1 Novel glyphosate-tolerant 5-enolpyruvylshikimate-3-phosphate synthase and gene encoding it |
11/02/2011 | EP1425389B1 Human antibodies specific for interleukin 15 (il-15) |
11/02/2011 | EP1299522B1 Alteration of cell membrane |
11/02/2011 | EP1212359B1 Method for detecting the expression of an envelope protein of a human endogenous retrovirus and uses of a gene coding for said protein |
11/02/2011 | EP1071710B2 Genomic sequence of the 5-lipoxygenase-activating protein (flap), polymorphic markers thereof and methods for detection of asthma |
11/02/2011 | EP1036180B2 Vaccine prepared with circovirus type b sequences related to piglet weight loss disease (pwd) |
11/02/2011 | CN1973031B Cells exhibiting neuronal progenitor cell characteristics |
11/02/2011 | CN1816279B Culture medium for the conservation of organs, biological tissues and living cells |
11/02/2011 | CN1753912B Antibodies against PD-1 and uses therefor |
11/02/2011 | CN102232111A Novel fructosyl peptide oxidase |
11/02/2011 | CN102232109A Biocompatible materials for mammalian stem cell growth and differentiation |
11/02/2011 | CN102229960A Method for transforming marrow cells to establish cell line by mouse leukemia viruses and application thereof |
11/02/2011 | CN102229945A Cultivation method for inducing scutellaria baicalensis hairy root based on agrobacterium rhizogenes infection |